Related Experiment Video

Updated: May 18, 2026

Experimental Metastasis Assay
08:28

Experimental Metastasis Assay

Published on: August 24, 2010

Rho GEFs and cancer: linking gene expression and metastatic dissemination

Laura Barrio-Real1, Marcelo G Kazanietz

  • 1Department of Pharmacology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Science Signaling
|October 4, 2012
PubMed

Insights

Guanine nucleotide exchange factors (GEFs) like Vav2 and Vav3 are crucial in breast cancer progression, driving tumor growth and metastasis. Targeting these GEFs offers potential new therapeutic strategies for breast cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Guanine nucleotide exchange factors (GEFs) regulate Rho and Rac GTPases, which are implicated in cancer progression.
  • Specific GEFs, such as P-Rex1 and P-Rex2a, have been linked to breast tumorigenesis.
  • Vav2 and Vav3 are identified as key GEFs involved in breast cancer.

Purpose of the Study:

  • To investigate the synergistic roles of Vav2 and Vav3 in breast cancer.
  • To elucidate the mechanisms by which Vav2 and Vav3 contribute to tumor growth, neoangiogenesis, and metastasis.
  • To identify novel therapeutic targets within the Vav-regulated signaling network.

Main Methods:

  • Analysis of Vav2 and Vav3 function in breast cancer models.
  • Transcriptome analysis to identify Vav-regulated genes.
  • Investigation of genes controlling metastatic dissemination to the lungs.

Main Results:

  • Vav2 and Vav3 exhibit synergistic roles in sustaining breast tumor growth.
  • These GEFs promote neoangiogenesis and metastasis in breast cancer.
  • A Vav-regulated transcriptome and specific metastasis-controlling genes were identified.

Conclusions:

  • Vav2 and Vav3 are critical regulators of breast cancer progression, influencing multiple hallmarks of cancer.
  • The identified Vav-regulated genes and pathways offer potential targets for novel breast cancer therapies.
  • Understanding Rho/Rac GTPase signaling networks is key to developing effective treatments.

More Related Videos

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...